Alpha Diagnostic International, Inc. Anti-Human Resistin-Like protein beta (RELM-beta/FIZZ2) IgG#2, aff. pure RELMB22-A

Anti-Human Resistin-Like protein beta (RELM-beta/FIZZ2) IgG#2, aff. pure General Information RELM-beta/FIZZ2 (prepeptides: mouse 105 aa; human 11 aa ~45-65% identity with FIZZ1 and 2) is highly related to resistin at the C-terminus region. Its expression is most abundant in colon (proximal and distal colon) but not in white adipose tissue. In m SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Human SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Affinity purified IgG SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 14-aa peptide from human RELM-beta (1); Designation (# RELMB22-P, control/blocking peptide) conjugated to KLH; epitope location ~ N-terminus SpCrossreactivity Human RELMB22-P sequence is only 42% conserved in human RELM-beta. We recommend the use of antibody Cat # RELMB22-S that is raised to human RELM-beta sequence. No significant sequence RELMB22-P was found with resistin or RELM-alpha. Antibody crossreactivity in various species is not established For research use only, not for diagnostic or therapeutic use.